Skip to content

Brief Intervention for Rural Women at High Risk for HIV/HCV

Brief Intervention for Rural Women at High Risk for HIV/HCV

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01840722
Acronym
WISH
Enrollment
400
Registered
2013-04-26
Start date
2012-12-31
Completion date
2019-05-31
Last updated
2019-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Immune Deficiency Syndrome Virus, Drug Abuse, Hepatitis C

Keywords

HIV, HCV, Substance abuse, women

Brief summary

The overall aim of this study is to reduce risk behaviors and increase health and behavioral health service utilization among disadvantaged, drug-using rural women at high risk for HIV and HCV. This project has potential to make a significant contribution to science by providing knowledge about the health, risk behaviors, and service utilization of a vulnerable and understudied group of women during a time of emerging and significant public health risk in a rural Appalachian setting. Successful completion of the aims of this project will advance the delivery of a low-cost, potentially high impact intervention with implications for a number of other real world settings (such as criminal justice venues) where other disadvantaged high-risk drug users can be identified and targeted for intervention.

Detailed description

Specific Aim 1: Compare the effectiveness of an evidence-based HIV risk reduction intervention (MI-HIV) to HIV Education (NIDA Standard) in reducing sex risk behaviors, injection practices, and drug use among a culturally unique sample of disadvantaged, drug-using rural women at high-risk for HIV and HCV. This aim will be accomplished through the random selection of high-risk rural women drug users from rural jails, screening and assessment for high-risk behavior, and random assignment to the HIV-Ed or MI-HIV intervention conditions. Follow-up interviews at 3, 6, and 12 months in the community post-release will examine changes in high-risk behavior. It is expected that MI-HIV participants will report significantly greater reductions in risky injection drug use practices, other drug use, and sex risk behaviors than women who participate in the HIV-Ed condition. Specific Aim 2: Examine MI-HIV Intervention engagement as a predictor of community health and behavioral health service utilization (including drug treatment and mental health) at follow-up among disadvantaged, drug-using rural women at high risk for HIV and HCV. This aim will focus on community service utilization during the follow-up period by the intervention and education comparison group, and how health and behavioral health service utilization relates to patterns of HIV/HCV risk behavior. It is expected that MI-HIV participants will utilize more services due to increased motivation for treatment and treatment planning following the brief intervention.

Interventions

OTHERMI-based HIV Risk Reduction

As the only MI-based intervention identified by the CDC as a best-practice model, the MI-HIV intervention has been shown to demonstrate positive outcomes for criminal justice-involved women randomly assigned to the intervention group for risky sexual activity and drug use with sustained behaviors through 9 months.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Michele Staton
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* ASSIST score of 4+ * engagement in at least one sex risk behavior in the past 3 months * willingness to participate in brief intervention sessions * no evidence of cognitive impairment * no evidence of active psychosis (currently experiencing hallucinations) * no self-reported current symptoms of physical withdrawal from a recent episode of drug use * incarceration period of 1 week - 3 months in order to complete intervention sessions

Exclusion criteria

* ASSIST score of \<4 * no engagement in at least one sex risk behavior in the past 3 months * not willing to participate in brief intervention sessions * evidence of cognitive impairment * evidence of active psychosis (currently experiencing hallucinations) * self-reported current symptoms of physical withdrawal from a recent episode of drug use * incarceration period of less than 1 week or greater than 3 months in order to complete intervention sessions

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Having Unprotected Casual Sex6 monthsHad unprotected sex with a casual partner or when trading sex for money, drugs, etc in the past 6 months

Secondary

MeasureTime frameDescription
Number of Participants Exchanging Sex6 monthsSex with a Partner in Exchange for Money, Drugs, Food, Shelter, Transportation, etc. in the past 6 months
Number of Participants Recently Receiving Physical or Behavioral Health Treatment6 monthsIs currently being treated for a physical or mental health problem OR has been in a substance use treatment program in the last 6 months

Countries

United States

Participant flow

Recruitment details

Adult women were randomly selected from three rural jails in Appalachia, screened, and interviewed face-to-face in a private room in the jail. Study eligibility included: 1) moderate risk of substance abuse based on the NIDA-ASSIST score of 4+ for any drug; 2) residing in Appalachia before incarceration; and 3) willingness to participate.

Pre-assignment details

Of the 688 screened, 248 (36%) did not meet eligibility criteria due to: not being released during time frame (n=203), not engaging in risky sexual practices (n=15), not being from Appalachian (n=21), and not meeting NM-ASSIST criteria (n=9). 440 (64%) met criteria, but 40 were released prior to completing the baseline. The final N=400.

Participants by arm

ArmCount
NIDA Standard HIV Education
NIDA Standard HIV Education Participants in this condition will be given HIV education using NIDA standard pre and post-test counseling, HIV and HCV rapid testing, and an information packet on existing community drug abuse and HIV/HCV resources
201
MI-based HIV Risk Reduction
MI-based HIV Risk Reduction -- In addition to what is received in the HIV-Ed group, participants in this condition will also receive a CDC evidence-based brief intervention for high-risk women focused on an individualized plan for enhancing motivation to reduce risk behaviors and to use health and behavioral health services in the community. MI-based HIV Risk Reduction: As the only MI-based intervention identified by the CDC as a best-practice model, the MI-HIV intervention has been shown to demonstrate positive outcomes for criminal justice-involved women randomly assigned to the intervention group for risky sexual activity and drug use with sustained behaviors through 9 months.
199
Total400

Baseline characteristics

CharacteristicNIDA Standard HIV EducationMI-based HIV Risk ReductionTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
201 Participants199 Participants400 Participants
Age, Continuous32.5 years
STANDARD_DEVIATION 8.4
33.1 years
STANDARD_DEVIATION 8.1
32.8 years
STANDARD_DEVIATION 8.2
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
1 Participants2 Participants3 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
200 Participants197 Participants397 Participants
Region of Enrollment
United States
201 participants199 participants400 participants
Risky Sexual Behavior84 Participants90 Participants174 Participants
Sex: Female, Male
Female
201 Participants199 Participants400 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
2 / 2011 / 199
other
Total, other adverse events
0 / 2010 / 199
serious
Total, serious adverse events
2 / 2011 / 199

Outcome results

Primary

Number of Participants Having Unprotected Casual Sex

Had unprotected sex with a casual partner or when trading sex for money, drugs, etc in the past 6 months

Time frame: 6 months

Population: Participants were lost to study attrition

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
NIDA Standard HIV EducationNumber of Participants Having Unprotected Casual Sex27 Participants
MI-based HIV Risk ReductionNumber of Participants Having Unprotected Casual Sex25 Participants
Secondary

Number of Participants Exchanging Sex

Sex with a Partner in Exchange for Money, Drugs, Food, Shelter, Transportation, etc. in the past 6 months

Time frame: 6 months

Population: Participants were lost to attrition.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
NIDA Standard HIV EducationNumber of Participants Exchanging Sex9 Participants
MI-based HIV Risk ReductionNumber of Participants Exchanging Sex8 Participants
Secondary

Number of Participants Recently Receiving Physical or Behavioral Health Treatment

Is currently being treated for a physical or mental health problem OR has been in a substance use treatment program in the last 6 months

Time frame: 6 months

Population: Participants were lost to study attrition.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
NIDA Standard HIV EducationNumber of Participants Recently Receiving Physical or Behavioral Health Treatment83 Participants
MI-based HIV Risk ReductionNumber of Participants Recently Receiving Physical or Behavioral Health Treatment84 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026